Topics in This Section
Patient Referral Resources
More information for Patients to help reach our Doctors
Read more »
Find Valuable Information about the Members of Our Staff
Read more »
Building the Profile:
Family History + Genetic Data
Our Risk Assessment Program (RAP) was one of the first in the nation to offer screening, education, and counseling to healthy people at increased genetic risk for disease.
A combination of your family history and your genetic data is used to build a profile of your risk for all cancer types, including — but not limited to — breast, ovarian, uterine, gastrointestinal (including colon), prostate, thyroid, and melanoma.
Clinical Genetics Staff List
Mary B. Daly, MD, PhD, FACP,
Chair, Clinical Genetics
Timothy R. Talbot Jr. Chair for Cancer Research; Co-Leader, Keystone Program in Personalized Risk and Prevention
Veda N Giri, MD,
Director, Prostate Cancer Risk Assessment, Clinical Genetics
Michael J. Hall, MD, MS,
Director, Clinical Risk Assessment, Clinical Genetics
Paula D. Ryan, MD, PhD,
Director, Breast and Ovarian Cancer Risk Assessment , Clinical Genetics
The Department of Clinical Genetics is closely aligned with ongoing research initiatives in Fox Chase's Cancer Prevention and Control Program, as well as its , a collaborative translational science program co-led by Daly and funded through philanthropic donations to Fox Chase.